Accessibility Menu
Ryman Healthcare logo

Ryman Healthcare(OTC) RYHTY

Current Price$6.11
Market Cap$1.24BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-65%
5 Year-86%
1 Year-9%
1 Month+0%
Ryman Healthcare last closing stock price
MetricPriceDate
Last closeUSD 6.112026-07-01
Ryman Healthcare stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 6.112026-06-12
1 month+0%USD 6.112026-05-27
3 month+0%USD 6.112026-04-02
Year to date-26.47%USD 8.312025-12-31
1 year-8.53%USD 6.682025-07-01
3 year-68.94%USD 19.672023-06-30
5 year-85.79%USD 43.002021-07-02
Since inception-64.89%USD 17.402013-01-11

Ryman Healthcare Financials at a Glance

Market Cap

$1.24BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

NZ$1.55B

Net Income (TTM)

-NZ$611.80M

EPS (TTM)

-$0.49

P/E Ratio

-12.39

Dividend

$0.00

Beta (Volatility)

0.20 (Low)

Price

$6.11

Volume

75

Open

$6.33

Previous Close

$6.11

Daily Range

$6.11 - $6.33

52-Week Range

$6.11 - $8.61

Estimated Earnings Date

May 26, 2026

RYHTY News

GettyImages-1306844370

Do Big Dividend Increases Make These 3 Medical Stocks Worth Buying?

James HalleyJul 9, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ryman Healthcare

Ryman Healthcare Limited, founded in 1984 and headquartered in Christchurch, New Zealand, specializes in developing, owning, and operating retirement communities and care facilities for the elderly across New Zealand and Australia. The company offers a range of living options, including independent townhouses, serviced apartments, and dedicated care facilities.

Products and Services
  • Comprehensive retirement communities with various living options
  • Residential aged care, hospital-level care, and specialized dementia care
  • On-site amenities including gyms, libraries, and dining facilities
Growth Outlook
  • Managed 45 retirement villages with over 8,500 units
  • Continued expansion in the aging population market
  • Investment in new facilities to enhance service offerings
Financial Highlights
  • Recent quarterly revenue of NZD 418.73 million
  • Trailing twelve months (TTM) net income margin of -0.31
  • Operating cash flow of NZD 155.72 million in the latest quarter
Ryman Healthcare Limited is positioned in a growing sector, catering to the increasing demand for elderly care services. The company’s extensive portfolio of retirement villages and care facilities reflects its commitment to providing quality living options for seniors. Despite recent financial challenges, including a negative net income margin, the company has demonstrated strong operating cash flow, indicating potential for future growth. The focus on expanding facilities and services aligns with the demographic trends of an aging population, suggesting a promising outlook for investors interested in the healthcare sector.
AI Generated • Jul 18, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

7,800

CEO

Naomi James

Website

www.rymanhealthcare.co.nz

Headquarters

Christchurch, CAN 8042, NZ

RYHTY Financials

Key Financial Metrics (TTM)

Gross Margin

-2.22%

Operating Margin

-2.22%

Net Income Margin

-21.46%

Return on Equity

-4.17%

Return on Capital

-0.32%

Return on Assets

-1.40%

Earnings Yield

-8.07%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.24BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

202.97M

Volume

75

Avg. Volume

3.387

Financials (TTM)

Gross Profit

-NZ$46.21M

Operating Income

-NZ$46.21M

EBITDA

-NZ$206.53M

Operating Cash Flow

NZ$732.72M

Capital Expenditure

-NZ$203.83M

Free Cash Flow

NZ$529.26M

Cash & ST Invst.

NZ$9.73M

Total Debt

NZ$1.60B

Ryman Healthcare Performance Analysis

Ryman Healthcare annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31NZD 348,957,895-0.5%
20242024-03-31NZD 396,620,14713.7%
20252025-03-31NZD 423,693,6696.8%
20262026-03-31NZD 468,779,96710.6%
Ryman Healthcare sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-0.2%
Q42025-03-311.6%
Q22025-09-306.5%
Q42026-03-316.0%
Ryman Healthcare annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31NZD 1.44-63.1%
20242024-03-31NZD -0.70N/A
20252025-03-31NZD -2.15207.7%
20262026-03-31NZD -0.50-76.9%
Ryman Healthcare sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30153.8%
Q42025-03-31-635.7%
Q22025-09-3094.1%
Q42026-03-31-192.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

NZ$418.73M

+14.4%

Gross Profit

-NZ$8.09M

-218.3%

Gross Margin

-1.93%

N/A

Market Cap

$1.24BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$158.99K

N/A

Employees

7,800

N/A

Net Income

-NZ$128.96M

+29.1%

EBITDA

NZ$13.11M

+105.1%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

NZ$9.73M

-81.3%

Total Debt

NZ$1.60B

-37.8%

Accounts Receivable

NZ$165.79M

-76.1%

Inventory

NZ$12.04K

-99.5%

Long Term Debt

NZ$1.45B

-43.7%

Short Term Debt

NZ$150.09M

N/A

Return on Assets

-1.40%

N/A

Return on Invested Capital

-0.15%

N/A

Free Cash Flow

NZ$126.48M

-47.5%

Operating Cash Flow

NZ$155.72M

-51.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNTLFGenetic Technologies Limited
$1.00+0.00%
LTGHYLife Healthcare Group Holdings Limited
$2.52+0.60%
LWSCFSienna Senior Living Inc.
$16.21-0.80%
NPPNYNippon Shinyaku Co., Ltd.
$6.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
FFord Motor Company
$14.37+0.02%
AALAmerican Airlines Group
$14.48+0.07%

Questions About RYHTY

What is the current price of Ryman Healthcare?

Ryman Healthcare is trading at $6.11 per share.

What is the 52-week range for Ryman Healthcare?

Over the past 52 weeks, Ryman Healthcare has traded between $6.11 and $8.61.

How much debt does Ryman Healthcare have?

As of the most recent reporting period, Ryman Healthcare reported total debt of NZ$908.10M.

How much cash does Ryman Healthcare have on hand?

Ryman Healthcare reported NZ$5.53M in cash and cash equivalents in its most recent financial results.

What is Ryman Healthcare’s dividend yield?

Ryman Healthcare does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services